Developer docs
API playgroundTry for free, no card

Search company profiles

Walk Vascular

Full company profile

uuid000bc8v

Namestring
Walk Vascular
Websiteurl
jeti.tv
Company typeenum
Private
Founded yearstring
-
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersIrvine, United States
HQ citystring
Irvine
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
mechanical thrombectomy devices, aspiration catheters, peripheral vascular devices, minimally invasive medical devices, thrombus removal systems
Industry2 codes
PRIMARYHLAHAFAJ
Thrombectomy, Embolic Protection & Stroke Intervention Devices
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAHAFAE
Peripheral Vascular Intervention (PAD Stents, Balloons, Atherectomy)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
NAICS code1 code
  • Medical Equipment and Supplies Manufacturing3391
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Peripheral Vascular Thrombectomy Devices
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales
TypeHardware Sales
Description

Abbott's Peripheral Vascular division generates revenue through the sale of disposable interventional devices including guide wires, balloon catheters, stents, atherectomy systems, embolic protection devices, and closure systems. These are predominantly single-use devices intended for one-time use only, creating recurring revenue from procedure volume.

cardiovascular.abbott
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Pricing details1 tier
1B2B enterprise sales model for healthcare providers
ModelOtherBilling cadencePay-as-you-go
Notes

Products are sold directly to hospitals, catheterization labs, and interventional radiology suites through Abbott's vascular sales organization. Pricing varies by facility, volume, and contract terms.

cardiovascular.abbott
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Walk Vascular is a commercial-stage medical device company that develops a minimally invasive mechanical aspiration thrombectomy system. The company's core product is designed for removing blood clots from peripheral vasculature through mechanical aspiration, addressing conditions such as peripheral artery disease and related thrombotic events. The company operates from Irvine, United States, with a focused product portfolio targeting interventional vascular procedures.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • PAD affects over 236 million people worldwide with prevalence in 15-20% of people over 70 years of age
Product and service1 record
1Minimally Invasive Mechanical Aspiration Thrombectomy System
CategoryPeripheral Vascular Thrombectomy Devices
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Cardiovascular Systems Inc. (CSI), a subsidiary of Abbott Group of Companies, manufactures the Diamondback 360 Peripheral Orbital Atherectomy System. Abbott distributes this product through its vascular sales channel, providing a comprehensive orbital atherectomy solution as part of its peripheral intervention portfolio.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Surmodics Inc. manufactures the SurVeil Drug-Coated Balloon, which is distributed by Abbott Group of Companies. This partnership provides Abbott with a differentiated paclitaxel-coated balloon technology for peripheral vascular interventions.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

Boston Scientific has a peripheral intervention portfolio that overlaps with the thrombectomy/peripheral vascular space and competes for hospital vascular procedure budgets.

TypeDirect peer
Description

Inari Medical develops mechanical thrombectomy systems (ClotTriever for DVT, FlowTriever for PE) and is the most direct competitor in the mechanical aspiration thrombectomy space since acquisition by Stryker.

TypeDirect peer
Description

Penumbra's Indigo Aspiration System is a leading mechanical aspiration thrombectomy platform for peripheral and venous applications, directly comparable to Walk Vascular's minimally invasive aspiration thrombectomy technology.

TypeDirect peer
Description

AngioDynamics markets mechanical thrombectomy and aspiration catheters (including AlphaVac for PE) addressing the same peripheral and venous clot-removal use cases targeted by Walk Vascular.

TypeEmerging player
Description

Cardio Flow is an emerging player developing mechanical thrombectomy technology for peripheral artery applications — directly overlapping with Walk Vascular's aspiration thrombectomy niche.

TypeBroad incumbent
Description

BD's peripheral vascular business includes catheters, guidewires, and intervention devices serving the same hospital vascular procedure accounts Walk Vascular targets.

TypeEmerging player
Description

Surmodics develops drug-coated balloon and peripheral surface coating technology (including partnership-manufactured devices like SurVeil distributed by Abbott) addressing peripheral vascular disease procedures adjacent to Walk Vascular's space.

TypeBroad incumbent
Description

Abbott offers the JETi All-in-One Peripheral Thrombectomy System as part of its broad peripheral intervention portfolio covering access, preparation, treatment, and closure — competing with Walk Vascular's aspiration thrombectomy system from a position of scale and breadth.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Walk Vascular

Peripheral Vascular Thrombectomy Devicesjeti.tv

Walk Vascular firmographics

Firmographics
Name
Walk Vascular
Website
https://jeti.tv
Company type
Private
Headcount range
1–10 employees
Ownership category
akta.pro rank

Walk Vascular industry classification

Industry
Product category
Peripheral Vascular Thrombectomy Devices
NAICS
Medical Equipment and Supplies Manufacturing (3391)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAFAJ
Thrombectomy, Embolic Protection & Stroke Intervention Devices
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAHAFAE
Peripheral Vascular Intervention (PAD Stents, Balloons, Atherectomy)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)

Keywords

  • Mechanical thrombectomy devices
  • Aspiration catheters
  • Peripheral vascular devices
  • Minimally invasive medical devices
  • Thrombus removal systems

Where Walk Vascular is headquartered

Location

Headquarters

HQ city
Irvine
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Walk Vascular business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Medical Device Sales: Abbott's Peripheral Vascular division generates revenue through the sale of disposable interventional devices including guide wires, balloon catheters, stents, atherectomy systems, embolic protection devices, and closure systems. These are predominantly single-use devices intended for one-time use only, creating recurring revenue from procedure volume.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goB2B enterprise sales model for healthcare providers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Walk Vascular product offering

Product offering

Core offering

Walk Vascular is a commercial-stage medical device company that develops a minimally invasive mechanical aspiration thrombectomy system. The company's core product is designed for removing blood clots from peripheral vasculature through mechanical aspiration, addressing conditions such as peripheral artery disease and related thrombotic events. The company operates from Irvine, United States, with a focused product portfolio targeting interventional vascular procedures.

Differentiator

Problem solved

Functional benefit

Products and services

  • Minimally Invasive Mechanical Aspiration Thrombectomy System

Quantifiable outcome

  • PAD affects over 236 million people worldwide with prevalence in 15-20% of people over 70 years of age

Companies that use Walk Vascular

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles1 record

Walk Vascular technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature10 records

Walk Vascular partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Cardiovascular Systems Inc. (CSI)coreOEM/ Whitelabel/ Licensing PartnerCardiovascular Systems Inc. (CSI), a subsidiary of Abbott Group of Companies, manufactures the Diamondback 360 Peripheral Orbital Atherectomy System. Abbott distributes this product through its vascular sales channel, providing a comprehensive orbital atherectomy solution as part of its peripheral intervention portfolio.
  • Surmodics Inc.coreOEM/ Whitelabel/ Licensing PartnerSurmodics Inc. manufactures the SurVeil Drug-Coated Balloon, which is distributed by Abbott Group of Companies. This partnership provides Abbott with a differentiated paclitaxel-coated balloon technology for peripheral vascular interventions.

Scale indicators2 records

Recent moves3 records

Expansion highlights2 records

Walk Vascular competitors and assessment

Company assessment

Broad incumbents

  • Boston Scientific: Boston Scientific has a peripheral intervention portfolio that overlaps with the thrombectomy/peripheral vascular space and competes for hospital vascular procedure budgets.
  • BD (Bard Peripheral Vascular): BD's peripheral vascular business includes catheters, guidewires, and intervention devices serving the same hospital vascular procedure accounts Walk Vascular targets.
  • Abbott (Peripheral Vascular Division): Abbott offers the JETi All-in-One Peripheral Thrombectomy System as part of its broad peripheral intervention portfolio covering access, preparation, treatment, and closure — competing with Walk Vascular's aspiration thrombectomy system from a position of scale and breadth.

Direct peers

  • Inari Medical (Stryker): Inari Medical develops mechanical thrombectomy systems (ClotTriever for DVT, FlowTriever for PE) and is the most direct competitor in the mechanical aspiration thrombectomy space since acquisition by Stryker.
  • Penumbra: Penumbra's Indigo Aspiration System is a leading mechanical aspiration thrombectomy platform for peripheral and venous applications, directly comparable to Walk Vascular's minimally invasive aspiration thrombectomy technology.
  • AngioDynamics: AngioDynamics markets mechanical thrombectomy and aspiration catheters (including AlphaVac for PE) addressing the same peripheral and venous clot-removal use cases targeted by Walk Vascular.

Emerging players

  • Cardio Flow: Cardio Flow is an emerging player developing mechanical thrombectomy technology for peripheral artery applications — directly overlapping with Walk Vascular's aspiration thrombectomy niche.
  • Surmodics: Surmodics develops drug-coated balloon and peripheral surface coating technology (including partnership-manufactured devices like SurVeil distributed by Abbott) addressing peripheral vascular disease procedures adjacent to Walk Vascular's space.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Walk Vascular social profiles

Digital presence

Walk Vascular financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Walk Vascular leadership team

Management profile

Number of profiles

Profiles1 record

Walk Vascular funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Walk Vascular M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Walk Vascular

What does Walk Vascular do?

Walk Vascular is a commercial-stage medical device company that develops a minimally invasive mechanical aspiration thrombectomy system. The company's core product is designed for removing blood clots from peripheral vasculature through mechanical aspiration, addressing conditions such as peripheral artery disease and related thrombotic events. The company operates from Irvine, United States, with a focused product portfolio targeting interventional vascular procedures.

When was Walk Vascular founded?

Walk Vascular was founded in -1. It employs 1 to 10 people.

Where is Walk Vascular based?

Walk Vascular is headquartered in Irvine, United States, in the North America region.

How does Walk Vascular make money?

One revenue line is on record: medical Device Sales.

Who are Walk Vascular's main competitors?

Broad incumbents on record are Boston Scientific, BD (Bard Peripheral Vascular) and Abbott (Peripheral Vascular Division). Direct peers are Inari Medical (Stryker), Penumbra and AngioDynamics. Emerging players are Cardio Flow and Surmodics.

Does Walk Vascular have an API?

No public API is recorded for Walk Vascular.

What industry is Walk Vascular in?

Walk Vascular's product category is Peripheral Vascular Thrombectomy Devices. Its primary akta.pro industry code is HLAHAFAJ, Thrombectomy, Embolic Protection & Stroke Intervention Devices, with a secondary code of HLAHAFAE, Peripheral Vascular Intervention (PAD Stents, Balloons, Atherectomy). Its NAICS code is 3391 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MedicaltubingandextrusionAbbott acquires Walk Vascular and its system to remove peripheral blood clotsAbbott acquired Walk Vascular and its minimally invasive mechanical aspiration thrombectomy system, with financial terms undisclosed. The JETi systems have FDA 510(k) clearance and CE mark, and Abbott is enrolling up to 250 patients in the JETi Registry. Abbott will integrate the systems into its endovascular product portfolio.BioSpaceAbbott Expands Peripheral Vascular Offerings with Acquisition of Walk Vascular, LLCAbbott Laboratories acquired Walk Vascular, a medical device company developing minimally invasive mechanical aspiration thrombectomy systems for peripheral blood clots. The systems, including JETi and JETi AIO, have received FDA 510(k) clearance and CE Mark, and Walk is enrolling up to 250 patients in the JETi Registry. Financial terms were not disclosed.PR NewswireAbbott Expands Peripheral Vascular Offerings with Acquisition of Walk Vascular, LLCAbbott has acquired Walk Vascular, LLC, a company that specializes in minimally invasive mechanical aspiration thrombectomy systems for removing peripheral blood clots, enhancing Abbott's vascular device portfolio. The acquisition aims to improve patient care through innovative thrombectomy technologies, which have received relevant regulatory approvals. Abbott's integration of Walk Vascular's systems is positioned to strengthen its offerings in endovascular therapy.News Release ArchiveAbbott Expands Peripheral Vascular Offerings with Acquisition of Walk Vascular, LLCAbbott announced the acquisition of Walk Vascular, LLC, a commercial-stage medical device company specializing in minimally invasive mechanical aspiration thrombectomy systems for treating peripheral blood clots. The acquired technology will be integrated into Abbott's existing endovascular product portfolio to expand its vascular offerings, though specific financial terms were not disclosed. This move aims to provide physicians with tools to efficiently remove dangerous clots from blood vessels.PR NewswireProximo Medical Selected as Commercialization Partner for Walk VascularProximo Medical announced it has been selected as the marketing and commercialization partner for Walk Vascular, a medical device company that developed the JETi Peripheral Thrombectomy Catheter. Walk Vascular just released its new JETi 88 device, which uses an internal jet mechanism to clear peripheral vessel blockages and demonstrated an 83% technical success rate in a 23-case study. The partnership aims to accelerate revenue growth by providing Walk Vascular with experienced direct sales representatives and commercialization expertise that startups typically cannot afford without additional funding.